Mucormycosis Clinical Core for the MUCOR-ADVANCE P01 Project

Launched by M.D. ANDERSON CANCER CENTER · Mar 10, 2025

Keywords

ClinConnect Summary

Primary Objective:

To establish MD Anderson Mucormycosis Clinical Core for the MUCOR-ADVANCE P01 Project.

* To prospectively identify, collect, and store all isolates causing proven or probable MCM in adult high-risk cancer participants.
* To prospectively identify, collect, and store relevant host samples from high-risk participants developing proven or probable MCM, along with relevant biospecimens from three control groups.
* To comprehensively annotate clinical specimens and provide information regarding the course and outcome of all MCM cases and controls.

OUTLINE:

This is an obser...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients must be 18-100 years old and have cancer and invasive mucormycosis, invasive aspergillosis, bacterial pneumonia, or a risk for fungal infection but no evidence of such infection.
• • Patients must be willing to undergo routine diagnostic procedures (e.g., phlebotomy, bronchoscopy, biopsy) as part of their regular care.
• Exclusion Criteria:
• • • Patients who are unwilling to undergo routine diagnostic procedures as part of their regular care.

Trial Officials